The Lancet Haematology in conversation with

Marc Riedl on hereditary angioedema

The Lancet Group

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 17:30

Professor Marc Riedl joins us to discuss two trials testing oral deucrictibant for hereditary angioedema attacks: one testing deucrictibant as on-demand therapy to treat attacks and the other testing deucrictibant for prophylaxis of attacks.

Click here to read the full articles:

https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(25)00341-2/fulltext 

https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(26)00004-9/fulltext

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv